HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals.

Abstract
Milrinone (Win 47203) is a potent cardiac bipyridine with inotropic and vasodilator properties. Its effects were studied in anesthetized and unanesthetized dogs and in isolated cardiac tissues from guinea pigs. In the anesthetized dog, the intravenous injection of milrinone (0.01-0.1 mg/kg) increased cardiac contractile force (CF) (23 +/- 6.1 to 87 +/- 8.9%), maximum left ventricular pressure development (24 +/- 5.8 to 119 +/- 16.1%), and cardiac output (16 +/- 4.5 to 33 +/- 8.9%), with less than a 30% increase in heart rate (HR). Significant decreases in systolic and diastolic blood pressures were seen at 0.3-3 mg/kg i.v. Oral doses of milrinone (0.1-1.0 mg/kg), in unanesthetized dogs, increased cardiac CF by 35 +/- 7.0 to 99 +/- 17.0%, with a maximum increase in HR of 40 +/- 7.1% and no significant change in blood pressure. Milrinone was effective in the presence of ouabain and dopamine without enhancing their arrhythmogenic properties. It was also effective in reversing propranolol-, verapamil-, or pentobarbital-induced heart failure. The inotropic response does not seem to involve the stimulation of the autonomic receptors, the release of endogenous catecholamines, histamine, or prostaglandins, or the inhibition of Na+,K+-adenosine triphosphatase. Milrinone is an inhibitor or cardiac adenosine 3',5'-monophosphate (cAMP) phosphodiesterase, with resultant increases in cardiac cAMP levels. However, the time course for this increase does not seem to correspond to the increase in muscle developed tension, and, therefore, it is unlikely to be responsible for the initiation of the inotropic response. Milrinone is a potent cardioactive agent which should be beneficial in the treatment of acute and chronic congestive heart failure.
AuthorsA A Alousi, J M Canter, M J Montenaro, D J Fort, R A Ferrari
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) 1983 Sep-Oct Vol. 5 Issue 5 Pg. 792-803 ISSN: 0160-2446 [Print] United States
PMID6195467 (Publication Type: Journal Article)
Chemical References
  • Pyridones
  • Propranolol
  • Verapamil
  • Cyclic AMP
  • Pentobarbital
  • Milrinone
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cardiac Output (drug effects)
  • Cyclic AMP (metabolism)
  • Dogs
  • Female
  • Heart (physiology)
  • Heart Failure (drug therapy)
  • In Vitro Techniques
  • Male
  • Milrinone
  • Myocardial Contraction (drug effects)
  • Pentobarbital (antagonists & inhibitors)
  • Propranolol (antagonists & inhibitors)
  • Pyridones (pharmacology)
  • Stimulation, Chemical
  • Verapamil (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: